Matt Dawson
CEO

TruDiagnostic offers epigenetic testing services that analyze DNA methylation patterns to provide insights into biological age and associated health risks. This analysis helps individuals and researchers understand how lifestyle and environmental factors influence gene expression, enabling tailored health strategies.
CEO
Founder
Individuals often lack a clear understanding of their biological aging process and how lifestyle choices impact their long-term health at a molecular level. Traditional health assessments may not capture the dynamic interplay between environmental factors and gene expression, leaving individuals without actionable insights to optimize their well-being and longevity.
TruDiagnostic offers a suite of epigenetic testing services that analyze DNA methylation patterns to provide a comprehensive view of an individual's biological age and overall health. Their tests, including TruAge and TruHealth, measure over 185 biomarkers, providing insights into organ system health, aging speed, and key nutritional and metabolic markers. By measuring the epigenome, which is influenced by lifestyle and environment, TruDiagnostic empowers individuals to understand how their genes are expressed and make targeted interventions to improve their healthspan. The company's CLIA-certified laboratory uses cutting-edge research and algorithms to deliver accurate and reliable results, enabling personalized health strategies.
TruDiagnostic's primary customers are individuals seeking to understand their biological age, optimize their healthspan, and make informed decisions about their lifestyle and nutrition, as well as healthcare providers and researchers interested in utilizing epigenetic data for personalized medicine and aging research.